RobertR.HenryMD

Diabetes, Lipid Metabolism

Professor of Medicine, University of California San Diego and Chief, Section of Diabetes, VA San Diego

Dr. Henry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3350 La Jolla Village Dr
111g
San Diego, CA 92161
Phone+1 858-642-3648

Fax+1 858-642-6242

PubMed

697 citations
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal, Linda Morrow, Hanns-Ulrich Marschall
Gastroenterology. 2013-09-01
94 citations
Alterations in Skeletal Muscle Indicators of Mitochondrial Structure and Biogenesis in Patients with Type 2 Diabetes and Heart Failure: Effects of Epicatechin Rich Cocoa
Pam R. Taub, Israel Ramirez-Sanchez, Theodore P. Ciaraldi, Guy Perkins, Anne N. Murphy
Clinical and Translational Science. 2012-02-01
43 citations
Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial.
Jeremy Pettus, Dominic N. Reeds, Tricia Santos Cavaiola, Schafer Boeder, Michelle Levin
Diabetes, Obesity & Metabolism. 2018-05-01

Journal Articles

Correction to: Mitochondrial H+-ATP Synthase in Human Skeletal Muscle: Contribution to Dyslipidaemia and Insulin Resistance
Pam Taub, Robert R Henry, Diabetologia

Elcelyx Therapeutics Reports Positive Results in Phase 2b Study of Metformin Delayed Release in Type 2 DiabetesNovember 11th, 2016
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Sglt-2 Inhibitors and Diabetic KetoacidosisApril 16th, 2016
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient with REMD-477, a Glucagon Receptor Monoclonal AntibodyApril 6th, 2016
Join now to see all

member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015